4.3.1 Esketamine (Spravato nasal spray) Intranasal administration of the ( S )-enantiomer of ketamine, esketamine (Spravato ), was initially approved by the FDA in 2019 for the treatment of adults with TRD and in 2020 for depression symptoms in adults with MDD with acute suicidal ideation or behavior (but not for treatment of the actual suicidality) [66, 120]
Expression of genes encoding alanine transporters in the cARLA-treated human co-culture model of BBB are shown from our previously published dataset publicly available at the Gene Expression Omnibus (GEO) under accession number GSE224846 [40]
When taking iron, it is best to avoid high-caffeine drinks like coffee or tea, as well as high-calcium foods like dairy, within an hour of your dose
DSIP has also been implicated in the regulation of several endocrine pathways
It has not received FDA approval and remains a research compound in the United States and most Western markets
Rotating injection sites prevents chronic irritation